ECOR Stock Analysis: Buy, Sell, or Hold?
ECOR - electroCore, Inc. Common Stock
$9.69
-0.83 (-7.89%)
▼
5d:
-5.46%
30d:
+56.54%
90d:
+45.28%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When ECOR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ECOR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ECOR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ECOR is currently trading at $9.69, which is considered extended relative to its 30-day fair value range of $5.89 to $9.57.
Technical Outlook: Technically, ECOR is in a uptrend. Immediate support is located at $7.68, while resistance sits at $10.95. Short-term momentum is weak, with the stock down 7.9% recently.
Market Sentiment: ECOR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.57 (+86.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ECOR is in a uptrend. Immediate support is located at $7.68, while resistance sits at $10.95. Short-term momentum is weak, with the stock down 7.9% recently.
Market Sentiment: ECOR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $19.57 (+86.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.89 -
$9.57
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.9%)
- BULLISH: Trading 86.0% below Wall St target ($19.57)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$5.89 -
$9.57
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$7.68
Resistance Level
$10.95
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-22.75
Wall Street Target
$19.57
(+86.0%)
Revenue Growth (YoY)
28.0%
Profit Margin
-40.0%
Share & Embed Analysis
Last updated: August 24, 2026 11:42 AM ET
Data refreshes hourly during market hours. Next update: 12:42 PM
Data refreshes hourly during market hours. Next update: 12:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ECOR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Daniel S Goldberger
SELL
16072 shares
2026-04-10
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 37 SELL |
